Research Roundtable
Identifying Opportunities & Priorities for Collaborative Research in Amyloidosis
Sunday, January 21 | 8-11:30 AM ET | Via Zoom
Creating consensus around the research priorities primed to increase the pace and efficiency of amyloidosis research that will most improve the lives of those with amyloidosis.
ARC has gathered global experts from academic, clinical, regulatory, health policy, and other key areas to create consensus around the unmet needs within amyloidosis and identify the research initiatives needed to ultimately improve patient outcomes. The key areas of focus include basic and translational research, clinical research, and overall clinical care within AL and ATTR amyloidosis.
Click Here to Register →Ashutosh Wechalekar, MD
MEETING CHAIR
University College London,
and Royal Free Hospital
Sarah Cairns-Smith
MEETING CHAIR
The Boston Consulting Group
Roundtable Agenda
8:00 am
Welcome
Moderator & Speaker: Isabelle Lousada, Amyloidosis Research Consortium
8:05 am
A Look Back in History & Forward Into the Future
Moderator & Speaker: Giampaolo Merlini MD, University of Pavia
8:20 am
Key Priorities in AL Amyloidosis: Advancing the Science of Clinical Trials
Moderator & Speaker: Morie Gertz MD, Mayo Clinic
8:30 am
Key Priorities in ATTR Amyloidosis: Advancing the Science of Clinical Trials
Moderator & Speaker: Rodney Falk MD, Brigham and Women’s Hospital, and Harvard Medical School
8:40 am
Key Priorities in Improving Clinical Care
Moderators & Speakers: Ashutosh Wechalekar MD, University College London, and Royal Free Hospital, and Mat Maurer MD, Columbia University Irving Medical Center
9:05 am
Recommendations of Working Groups
Open Meeting
11:05 am
What Have I Heard?
Moderators & Speakers: Preston Dunnmon MD, Janssen Research and Development, and Morie Gertz MD, Mayo Clinic
11:25 am
Meeting Close
Moderator & Speaker: Isabelle Lousada, Amyloidosis Research Consortium